MANNKIND CORP Accrued Liabilities and Other Liabilities
MANNKIND CORP (MNKD) had Accrued Liabilities and Other Liabilities of $900.00 thousand as of 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2023-02-23
- 2022-12-31: Accrued Liabilities and Other Liabilities $900.00K.
- 2022-09-30: Accrued Liabilities and Other Liabilities $900.00K.
- 2022-03-31: Accrued Liabilities and Other Liabilities $1.10M.
- 2021-12-31: Accrued Liabilities and Other Liabilities $1.10M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2022-12-31 | $900.00K 10-K · filed 2023-02-23 |
| 2022-09-30 | $900.00K 10-Q · filed 2022-11-08 |
| 2022-03-31 | $1.10M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.10M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |